台新藥(6838) 三大法人買賣超歷史
上市 · 單位為張(1 張 = 1,000 股)
台新藥(6838) 在 2025-09-22 至 2026-09-21 期間,三大法人合計淨買超 1,587 張。這段期間共 235 個交易日有法人進出紀錄,其中 128 天為買超,佔 54%。收盤價自 2026-08-10 的 23.35 至 2026-09-21 的 23.9,上漲 2.4%。收盤價僅採用交易所開放資料,起始日因此晚於法人買賣超序列。累計值自本區間起點起算,代表期間內的淨買賣,不是法人持股量。
區間累計
+1,587張|三大法人淨買超
- 資料區間
- 2025-09-22 ~ 2026-09-21
- 交易日數
- 235
- 最新一日合計
- +16
逐日買賣超與累計
近 60 個交易日
單位為張,紅色為買超、綠色為賣超。累計欄為自區間起點起算的淨買超。
| 日期 | 外資 | 投信 | 自營商 | 合計 | 累計 |
|---|---|---|---|---|---|
| +14 | 0 | +2 | +16 | 1,587 | |
| −55 | 0 | +16 | −39 | 1,571 | |
| −1 | 0 | +2 | +1 | 1,609 | |
| −7 | 0 | 0 | −7 | 1,608 | |
| −20 | 0 | −3 | −23 | 1,615 | |
| +14 | 0 | +2 | +16 | 1,638 | |
| −13 | 0 | 0 | −13 | 1,622 | |
| 0 | 0 | +1 | +1 | 1,635 | |
| +8 | 0 | 0 | +8 | 1,634 | |
| +29 | 0 | −1 | +28 | 1,626 | |
| +95 | 0 | +1 | +96 | 1,598 | |
| +88 | 0 | 0 | +88 | 1,502 | |
| −3 | 0 | +1 | −2 | 1,414 | |
| −23 | 0 | 0 | −23 | 1,416 | |
| +5 | 0 | +2 | +7 | 1,439 | |
| +12 | 0 | 0 | +12 | 1,432 | |
| −6 | 0 | 0 | −6 | 1,420 | |
| −3 | 0 | 0 | −3 | 1,426 | |
| +4 | 0 | 0 | +4 | 1,429 | |
| −15 | 0 | 0 | −15 | 1,425 | |
| −36 | 0 | 0 | −36 | 1,440 | |
| 0 | 0 | +3 | +3 | 1,476 | |
| −11 | 0 | 0 | −11 | 1,473 | |
| −13 | 0 | 0 | −13 | 1,484 | |
| −4 | 0 | 0 | −4 | 1,497 | |
| +1 | 0 | 0 | +1 | 1,501 | |
| −62 | 0 | +1 | −61 | 1,500 | |
| −10 | 0 | 0 | −10 | 1,561 | |
| −50 | 0 | −4 | −54 | 1,571 | |
| +26 | 0 | +3 | +29 | 1,625 | |
| +20 | 0 | −2 | +18 | 1,596 | |
| −3 | 0 | +2 | −1 | 1,578 | |
| +119 | 0 | +1 | +120 | 1,579 | |
| +68 | 0 | +1 | +69 | 1,459 | |
| +31 | 0 | −1 | +30 | 1,390 | |
| −19 | 0 | 0 | −19 | 1,360 | |
| −4 | 0 | −6 | −10 | 1,379 | |
| −7 | 0 | 0 | −7 | 1,389 | |
| +56 | 0 | 0 | +56 | 1,396 | |
| −25 | 0 | +1 | −24 | 1,341 | |
| −9 | 0 | +1 | −8 | 1,365 | |
| +33 | 0 | +5 | +38 | 1,373 | |
| −3 | 0 | +6 | +3 | 1,335 | |
| −28 | 0 | 0 | −28 | 1,332 | |
| +23 | 0 | 0 | +23 | 1,360 | |
| +10 | 0 | −2 | +8 | 1,337 | |
| +31 | 0 | −2 | +29 | 1,329 | |
| −87 | 0 | +4 | −83 | 1,300 | |
| +91 | 0 | −2 | +89 | 1,383 | |
| −23 | 0 | 0 | −23 | 1,294 | |
| +13 | 0 | +2 | +15 | 1,317 | |
| +30 | 0 | 0 | +30 | 1,302 | |
| +58 | 0 | 0 | +58 | 1,272 | |
| −65 | 0 | −3 | −68 | 1,214 | |
| +14 | 0 | 0 | +14 | 1,282 | |
| +48 | 0 | 0 | +48 | 1,268 | |
| +71 | 0 | 0 | +71 | 1,219 | |
| −39 | 0 | −2 | −41 | 1,149 | |
| +3 | 0 | +3 | +6 | 1,190 | |
| −18 | 0 | +2 | −16 | 1,184 |
相關頁面
回到台新藥(6838) 個股概況查看價格與最近 20 日法人進出,或到全市場籌碼走勢看外資、投信、自營商在整個市場的動向與融資融券餘額。
單位為股(1 張 = 1,000 股)。累計淨買超自本區間起點起算,代表這段期間的法人淨買賣,不是法人持股量。證交所個股日報只提供股數、不提供金額。本頁數據僅供研究參考,不構成投資建議。